🇺🇸 FDA
Patent

US 7161012

Processes for preparing amorphous atorvastatin hemi-calcium

granted A61KA61K9/282A61K9/5021

Quick answer

US patent 7161012 (Processes for preparing amorphous atorvastatin hemi-calcium) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K9/282, A61K9/5021, A61P, A61P3/06